A novel KPC-166 in ceftazidime/avibactam resistant ST307 Klebsiella pneumoniae causing an outbreak in intensive care COVID Unit, Italy
-
Published:2024-06
Issue:3
Volume:57
Page:457-469
-
ISSN:1684-1182
-
Container-title:Journal of Microbiology, Immunology and Infection
-
language:en
-
Short-container-title:Journal of Microbiology, Immunology and Infection
Author:
Piazza Aurora,
Mattioni Marchetti VittoriaORCID,
Bielli Alessandra,
Biffignandi Gherard Batisti,
Piscopiello Francesca,
Giudici RiccardoORCID,
Tartaglione Livia,
Merli MarcoORCID,
Vismara Chiara,
Migliavacca RobertaORCID
Reference35 articles.
1. Carbapenems: past, present, and future;Papp-Wallace;Antimicrob Agents Chemother,2011
2. Global dissemination of carbapenemase-producing Klebsiella pneumoniae: Epidemiology, genetic context, treatment options, and detection methods;Lee;Front Microbiol,2016
3. Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in The Netherlands 2017-2019;Wielders;Antimicrob Resist Infect Control,2022
4. Resistance to ceftazidime/avibactam in infections and colonisations by KPC-producing Enterobacterales: a systematic review of observational clinical studies;Di Bella;J Glob Antimicrob Resist,2021
5. Resistance to ceftazidime-avibactam and underlying mechanisms;Wang;J Glob Antimicrob Resist,2020